/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

ALPHA TAU MEDICAL LTD-CL A

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$4.14 0.0026(0.26%) DRTS at 04 Dec 2025 04:30 PM Biotechnology
Lowest Today 3.82
Highest Today 3.86
Today’s Open 3.86
Prev. Close 3.87
52 Week High 4.69
52 Week Low 2.30
Day’s Range: Low 3.82 High 3.86
52-Week Range: Low 2.30 High 4.69
1 day return -
1 Week return -3.25
1 month return +0.52
3 month return +10.91
6 month return +21.38
1 year return +28.66
3 year return +0.25
5 year return -
10 year return -

Institutional Holdings

HighTower Advisors, LLC 0.81

Kovitz Investment Group Partners, LLC 0.24

Easterly Investment Partners. 0.23

Citadel Advisors Llc 0.08

Satovsky Asset Management LLC 0.06

Private Advisor Group, LLC 0.06

Northern Trust Corp 0.05

Mariner Wealth Advisors LLC 0.05

Morgan Stanley - Brokerage Accounts 0.05

Fidelity Nasdaq Composite Index 0.04

Geode Capital Management, LLC 0.04

UBS Group AG 0.04

Renaissance Technologies Corp 0.03

Merlin MSMID50 0.03

Atom Investors LP 0.03

Aptus Capital Advisors, LLC 0.03

Equitable Holdings Inc 0.01

Opal Wealth Advisors, LLC 0.01

Tower View Investment Management & Research LLC 0.01

Bessemer Group Inc 0.00

Steward Partners Investment Advisory, LLC 0.00

Wells Fargo & Co 0.00

Market Status

Strong Buy: 2

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 329.97 M

PB Ratio 4.1267

PE Ratio 0.0

Enterprise Value 261.46 M

Total Assets 86.20 M

Volume 38995

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-25188000 -25.2M, FY22:-33762000 -33.8M, FY21:-27271000 -27.3M, FY20:-8882000 -8.9M, FY19:-8464000 -8.5M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-11686000 -11.7M, Q2/2025:-10114000 -10.1M, Q1/2025:-8691000 -8.7M, Q3/2024:-6924000 -6.9M, Q2/2024:-7369000 -7.4M

Fund house & investment objective

Company Information Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

Organisation Biotechnology

Employees 125

Industry Biotechnology

CEO Mr. Uzi Sofer

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow